Global Pancreatin Market Outlook 2017-2022

The global pancreatin market is expected to display higher growth rate by next five years. The pancreatin market is subject to witness a substantial growth due to the increasing adoption of pancreatin for treatment of exocrine pancreatic insufficiency and other digestive disorders. The growing number of incidences of cystic fibrosis, complex surgical pancreatectomy, and chronic pancreatitis are expected to boost market demand for pancreatin over the forecast period. 

Pancreatin is an amalgamation of various digestive enzymes that are made from the exocrine cells of the pancreas. Globally, the pancreatin market is predicted to generate massive revenue in the forecast period, providing numerous opportunities for market players to invest in research and development of the pancreatin enzymes.

Pancreatin is largely adopted to produce necessary digestive enzymes. During certain medical conditions human body is not able to produce required digestive enzymes of its own, in such cases, pancreatin drugs or injection are given. Additionally, rising prevalence of disorders such as cystic fibrosis, pancreatitis, pancreatic cancer, or pancreas surgery leads to inefficiency of digestive enzymes in the human body. These factors are expected to drive the growth of pancreatin market over the forecast period. Pancreatin has also found its use during treatment of medical a condition called steatorrhea or fatty stools, thereby positively affecting market growth, in the recent years. 

The recent technological advancements in the pharmaceutical & medicine sector coupled with development of novel drugs are expected to foster market growth in the upcoming years. Pancreatin mostly consists of essential digestive enzymes such as lipase, amylase and protease. Enzyme treatment consisting of pancreatin is largely adopted by various healthcare professionals for the treatment of cystic fibrosis, inflammation of the pancreas, pancreatic cancer, and surgical pancreatic removal, in which deficiency of pancreatic enzymes commonly occurs in the patients. Pancreatin offers advantages such as reducing in the iron absorption from food and hydrolyzing of proteins in the duodenum during digestion.

The pancreatin market is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the implementation of latest technologies in the pharmaceutical & medicine sector, increasing research & development activities in the region, growing health awareness among general population and existence of well-established healthcare infrastructure. Asia-Pacific region is predicted to hold major market share in the pancreatin market with massive growth in forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with growing geriatric population, improved healthcare infrastructure, increase in per capita income, higher approval rate for novel drugs and significant investment by leading industry players considering the potential growth opportunities in the region.

The key players in the pancreatin market are American Laboratories, Inc., Nordmark Arzneimittel GmbH & Co., KG, Biocatalysts Ltd., Bovogen Biologicals Pty Ltd., Rossari Biotech Ltd., Sichuan Biosyn Pharmaceutical Co., Ltd., Sichuan Deebio Pharmaceutical Co., Ltd., Chongqing Aoli Biopharmaceutical Co., Ltd., Changzhi Sanbao Biochemical Pharmaceutical Co., Ltd., Sichuan Friendly Pharmaceutical Co., Ltd., and Shenzhen Hepalink Pharmaceutical Co., Ltd.

The global market for pancreatin will grow at a CAGR of 4.1% by 2022, according to a new report published by Gen Consulting Company. The report segments the market and forecasts its size, by volume and value, on the basis of application (pharmaceutical, food & dairy, etc.), and by geography (North America, Europe, Asia-Pacific, MEA and South America).

The report covers forecast and analysis for the pancreatin market on a global and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both output/volume and revenue. The study then describes the drivers and restraints for the pancreatin market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pancreatin market on a global level.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global pancreatin market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.

Demand for this market rises from the pharmaceutical, food & dairy, and other applications. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022. Relevantly, the report and company profiles specify the key drivers that are impacting the demand in global pancreatin market.

Key Applications
- Pharmaceutical
- Food & Dairy

Key Regions
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America

Key Vendors
- ALI
- Chongqing Aoli
- Chongqing Jingkang
- Nordmark
- Shenzhen Hepalink
- Sichuan Deebio
- request free sample to get a complete list of companies

Key Questions Answered in this Report
- What will the market size be in 2022?
- What are the key factors driving the global pancreatin market?
- What are the challenges to market growth?
- Who are the key players in the pancreatin market?
- What are the market opportunities and threats faced by the key players?